Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension

Journal of Hypertension

Volumn 32, Issue 9, 2014, Pages 1898-1904

  Inomata, Jun Ichiro ^a   Murai, Hisayoshi ^a   Kaneko, Shuichi ^a   Hamaoka, Takuto ^a   Ikeda, Tatsunori ^a   Kobayashi, Daisuke ^a   Usui, Soichiro ^a   Furusho, Hiroshi ^a   Sugiyama, Yu ^b   Takata, Shigeo ^b   Takamura, Masayuki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Kanazawa Municipal Hospital   (Japan)

Author keywords

baroreceptor reflex; calcium channel blocker; hypertension; muscle sympathetic nerve activity

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; AZELNIDIPINE; AZETIDINE 2 CARBOXYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART HEMODYNAMICS; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; ADRENERGIC SYSTEM; ANALOGS AND DERIVATIVES; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; AZETIDINECARBOXYLIC ACID; BAROREFLEX; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DIHYDROPYRIDINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84906092308     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000270     Document Type: Article

References (33)

1. Abernethy DR, Schwartz JB. Calcium-Antagonist drugs. N Engl J Med 1999; 341:1447-1457
2. Alderman MH, Cohen H, Roque R, Madhavan S. Effect of long-Acting and short-Acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997; 349:594-598
3. Grassi G, Seravalle G, Turri C, Bolla G, Mancia G. Short-versus longterm effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension 2003; 41:558-562
4. Takami T, Saito Y. Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: A randomized trial. Drug Des Dev Ther 2013; 7:175-183
5. Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Cavazzini C, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A metaanalysis of randomised controlled trials. Lancet 2000; 356:1949-1954
6. Fujisawa M, Yorikane R, Matsuoka Y, Koike H, Ueno K. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: Azelnidipine and amlodipine. J Cardiovasc Pharmacol 2013; 61:63-69
7. Nakamoto M, Ohya Y, Sakima A, Yamazato M, Takishita S. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats. Hypertens Res 2007; 30:359-366
8. Shokoji T, Fujisawa Y, Kiyomoto H, Rahman M, Sun GP, Fan YY, et al. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats. Hypertens Res 2005; 28:1017-1023
9. Nada T, Nomura M, Koshiba K, Kawano T, Mikawa J, Ito S. Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity. Arzneimittelforschung 2007; 57:698-704
10. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3-107
11. Ikeda T, Murai H, Kaneko S, Usui S, Kobayashi D, Nakano M, et al. Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation. J Physiol 2012; 590:509-518
12. Kobayashi D, Takamura M, Murai H, Usui S, Ikeda T, Inomata J, et al. Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with alpha-glucosidase inhibitor. Auton Neurosci 2010; 158:86-91
13. Murai H, Takamura M, Maruyama M, Nakano M, Ikeda T, Kobayashi D, et al. Altered firing pattern of single-unit muscle sympathetic nerve activity during handgrip exercise in chronic heart failure. J Physiol 2009; 587:2613-2622
14. Fagius J, Wallin BG. Long-Term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 1993; 3:201-205
15. Hoffman RP, Sinkey CA, Anderson EA. Microneurographically determined muscle sympathetic nerve activity levels are reproducible in insulin-dependent diabetes mellitus. J Diabetes Complications 1998; 12:307-310
16. Grassi G, Seravalle G, DellOro R, Arenare F, Facchetti R, Mancia G. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity. Nutr Metab Cardiovasc Dis 2009; 19:469-475
17. Heart rate, variability., standards of measurement, physiological interpretation and clinical, use., Task Force of the European Society of Cardiology and the North American Society of Pacing and, Electrophysiology. Circulation 1996; 93:1043-1065
18. Parati G, Frattola A, Di Rienzo M, Castiglioni P, Pedotti A, Mancia G. Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol 1995; 268:H1606-H1612
19. Lambert E, dUdekem Y, Cheung M, Sari CI, Inman J, Ahimastos A, et al. Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol 2013; 167:1333-1338
20. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34:724-728
21. Struck J, Muck P, Trubger D, Handrock R, Weidinger G, Dendorfer A, et al. Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens 2002; 20:1143-1149
22. Iribe G, Kaihara K, Ito H, Naruse K. Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes. Eur J Pharmacol 2013; 715:142-146
23. Konno S, Hirooka Y, Araki S, Koga Y, Kishi T, Sunagawa K. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2008; 52:555-560
24. Goldstein DS, Horwitz D, Keiser HR. Comparison of techniques for measuring baroreflex sensitivity in man. Circulation 1982; 66:432-439
25. Goldman WF, Saum WR. A direct excitatory action of catecholamines on rat aortic baroreceptors in vitro. Circ Res 1984; 55:18-30
26. Pardini BJ, Lund DD, Schmid PG. Contrasting preganglionic and postganglionic effects of phenylephrine on parasympathetic control of heart rate. Am J Physiol 1991; 260:H118-H120
27. Musialek P, Lei M, Brown HF, Paterson DJ, Casadei B. Nitric oxide can increase heart rate by stimulating the hyperpolarization-Activated inward current I(f). Circ Res 1997; 81:60-68
28. Hogan N, Kardos A, Paterson DJ, Casadei B. Effect of exogenous nitric oxide on baroreflex function in humans. Am J Physiol 1999; 277:H221-H227
29. Rea RF, Eckberg DL. Carotid baroreceptor-muscle sympathetic relation in humans. Am J Physiol 1987; 253:R929-R934
30. Tanaka H, Namekata I, Ogawa T, Tsuneoka Y, Komikado C, Takahara A, et al. Effects of S-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3. 1 Eur J Pharmacol 2010; 649:263-267
31. Qu Y, Baroudi G, Yue Y, Boutjdir M. Novel molecular mechanism involving alpha1D (Cav1.3) L-Type calcium channel in autoimmune-Associated sinus bradycardia. Circulation 2005; 111:3034-3041
32. Fujisawa M, Yorikane R, Chiba S, Koike H. Chronotropic effects of azelnidipine, a slow-And long-Acting dihydropyridine-Type calcium channel blocker, in anesthetized dogs: A comparison with amlodipine. J Cardiovasc Pharmacol 2009; 53:325-332
33. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992; 453:45-58.